(Q51707713)

English

Circulating interleukin 16 (IL-16) in children with atopic/eczema dermatitis syndrome (AEDS): a novel serological marker of disease activity.

scientific article published in September 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/12169178

Circulating interleukin 16 (IL-16) in children with atopic/eczema dermatitis syndrome (AEDS): a novel serological marker of disease activity. (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/12169178

author name string

Frezzolini A

1

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/12169178

Paradisi M

2

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/12169178

Zaffiro A

3

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/12169178

Provini A

4

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/12169178

Cadoni S

5

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/12169178

Ruffelli M

6

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/12169178

De Pità O

7

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/12169178

publication date

1 September 2002

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/12169178

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/12169178

57

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/12169178

9

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/12169178

815-820

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/12169178

Atopic dermatitis: new insights and opportunities for therapeutic intervention

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23687.X

21 January 2018

A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23687.X

21 January 2018

Cellular and immunologic mechanisms in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23687.X

21 January 2018

Chemokines and leukocyte traffic

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23687.X

21 January 2018

Chemokines: immunology's high impact factors

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23687.X

21 January 2018

Chemokines and disease

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23687.X

21 January 2018

Serum macrophage-derived chemokine (MDC) levels are closely related with the disease activity of atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23687.X

21 January 2018

A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23687.X

21 January 2018

Thymus and activation-regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23687.X

21 January 2018

Signaling and functional properties of interleukin-16.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23687.X

21 January 2018

Interleukin 16: implications for CD4 functions and HIV-1 progression

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23687.X

21 January 2018

Association of increased CD4+ T-cell infiltration with increased IL-16 gene expression in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23687.X

21 January 2018

Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23687.X

21 January 2018

Chemoattractant receptors expressed on type 2 T cells and their role in disease.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23687.X

21 January 2018

Chemokines, chemokine receptors and allergy

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23687.X

21 January 2018

Keratinocytes from patients with atopic dermatitis and psoriasis show a distinct chemokine production profile in response to T cell-derived cytokines

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23687.X

21 January 2018

Inducible expression of a CC chemokine liver- and activation-regulated chemokine (LARC)/macrophage inflammatory protein (MIP)-3 alpha/CCL20 by epidermal keratinocytes and its role in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23687.X

21 January 2018

Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23687.X

21 January 2018

Urinary eosinophil protein X and serum eosinophil cationic protein in infants and young children with atopic dermatitis: correlation with disease activity.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23687.X

21 January 2018

Serum levels of soluble stem cell factor and soluble KIT are elevated in patients with atopic dermatitis and correlate with the disease severity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23687.X

21 January 2018

Soluble E-selectin correlates with disease activity in cyclosporin A-treated patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23687.X

21 January 2018

A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23687.X

7 January 2021

based on heuristic

inferred from DOI database lookup

The C-C chemokines, RANTES and eotaxin, in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23687.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced expression of eotaxin and CCR3 in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23687.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased plasma eotaxin in atopic dermatitis and acute urticaria in infants and children

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23687.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence for increased expression of eotaxin and monocyte chemotactic protein-4 in atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23687.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased expression of IL-16 immunoreactivity in bronchial mucosa after segmental allergen challenge in patients with asthma

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23687.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased expression of the chemoattractant cytokines eotaxin, monocyte chemotactic protein-4, and interleukin-16 in induced sputum in asthmatic patients

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23687.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Circulating interleukin-16 in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23687.X

7 January 2021

based on heuristic

inferred from DOI database lookup

A possible pathogenic role of CD8+ T cells and their derived cytokine, IL-16, in SLE.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23687.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Soluble CD30 in pediatric patients with atopic dermatitis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23687.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclosporin A (CyA) reduces sCD30 serum levels in atopic dermatitis: a possible new immune intervention

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23687.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Engagement of the Fc epsilon RI stimulates the production of IL-16 in Langerhans cell-like dendritic cells

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2002.23687.X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1034/J.1398-9995.2002.23687.X

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/12169178

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 April 2018

http://europepmc.org/abstract/MED/12169178

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51707713&oldid=1452111140"